Introduction
IgA nephropathies (IgA NP)' represent one ofthe most common groups ofglomerulonephritides in humans (1) . Diffuse mesangial localization of IgA in kidney biopsy specimens from patients with IgA NP is the most distinctive feature of the disease. Nonetheless, it has now become clear that, in addition to idiopathic IgA NP (Berger's disease), several other diseases, such as HenochSchoenlein purpura, celiac disease, alcoholic liver cirrhosis, and dermatitis herpetiformis share this common immunopathologic feature (2) (3) (4) (5) (6) (7) (8) (9) (10) .
A putative nephritogenic role has been ascribed to IgA-containing circulating immune complexes (CIC) in mesangial IgA NP ( 1). This concept has arisen from early immunohistologic studies performed on kidney biopsy specimens of IgA NP patients showing mesangial deposits of IgA with a granular pattern, similar to that observed in other glomerulonephritides in which CIC are thought to play a major inflammatory role (12) . The 1. Abbreviations used in this paper: CIC, circulating immune complexes; ELISA, enzyme-linked immunosorbent assay; FBS, fetal bovine serum; IgA NP, IgA nephropathy; PAP, horseradish peroxidase IgG antiperoxidase antibody complexes; PEG, polyethylene glycol; RF, rheumatoid factor; RIA, radioimmunoassay; SDU, standard deviation units. frequent presence of complement components in these deposits (1) , the inability to demonstrate convincingly antimesangial antibodies in the sera of IgA NP patients (7) , and the recurrence of IgA nephropathy in renal allografts (13) are compatible with the view that IgA-containing CIC are deposited in the glomeruli. This hypothesis has gained further support from recent studies demonstrating elevated levels of CIC that contain IgA not only in patients with primary IgA NP (14) (15) (16) (17) (18) (19) (20) , but also in patients with Henoch-Schoenlein purpura (16, (21) (22) (23) , dermatitis herpetiformis (23, 24) , and IgA NP associated with liver cirrhosis (25, 26) . In rodents, IgA-containing CIC either infused (27) or induced by enteral (28) or parenteral (29) immunization with defined antigens can deposit in the mesangium and initiate a proliferative glomerulonephritis similar to that observed in humans. Despite this, attempts to isolate a specific IgA-CIC-associated antigen in humans have been unsuccessful and the pathogenic role of these CIC remains elusive.
Initial immunofluorescence studies with polyclonal antisera suggested that IgA2 was the predominant subclass of IgA in glomerular deposits of patients with mesangial IgA NP (30) . In contrast, more recent studies with subclass-specific monoclonal antibodies have indicated that IgA 1 is the predominant, often exclusive, subclass present in these deposits (18, (31) (32) (33) (34) . In addition to the absence of detectable secretory component (15, 35, 36) , these observations suggest that the IgA deposited may not be of secretory origin. Less information (26) is available regarding the properties of IgA present in CGC-like material detected in patients with mesangial IgA NP. Such information could provide clues as to the origin, be it mucosal or systemic, of the IgA component of these CIC.
In addition to IgA-CIC, CIC that contain IgG have been detected in patients with IgA NP (16, 19, 20) , Henoch-Schoenlein purpura (16, 19, 21, 22) and alcoholic liver cirrhosis (25, 37, 38 (34) and the absence of the manifestations of other systemic diseases. The diagnosis of Henoch-Schoenlein purpura was established in one patient in whom the above immunofluorescence findings of IgA NP were accompanied by abdominal pain, joint pain, and purpura. Of the remaining three patients, one had dermatitis herpetiformis, one had had a previous kidney biopsy with diagnosis of focal glomerulosclerosis and one had coincidental diabetes mellitus. 21 of the patients were white males, one was a black male, and the remainder were white females; this distribution is in keeping with previously reported demographic data (39, 40) . Ages ranged from 9 to 82 yr (median 26 yr). Serum creatinine concentrations ranged from 0.5 to 15.2 mg/dl (median 1.0 mg/dl). Two patients had received kidney transplants which function normally. The 24-h urinary protein excretion ranged from 0 to 4.9 g (median 0.7) and the magnitude of hematuria from 0 to 1,000 red blood cells per high power field (median 5).
21 healthy laboratory volunteers (median age 31 yr, ranging from 17 to 53 yr) were utilized as controls.
CIC assays. Freshly separated serum samples were precipitated with polyethylene glycol (PEG) (PEG 6000, Fisher Scientific, Orangeburg, NY) using the conditions detailed by Kauffman et al. (41) to prepare fractions enriched for CIC. Before analysis, each PEG precipitate was redissolved in 1 ml of 0.01 M phosphate buffer, pH 7.4, containing 0.5 M NaCl, 0.05% Tween 20 and 5% fetal bovine serum (FBS, Irvine Scientific, Santa Ana, CA) (CIC buffer).
Levels of CIC containing C3 and IgA, IgG, or IgM were estimated by a modification (42) of the solid-phase anti-C3 assay (43) . Individual wells of microtiter plates (Linbro, Flow Laboratories, Inc., McLean, VA) were coated overnight with F(ab')2 fragments of goat anti-human C3 (Cooper Diagnostics, West Chester, PA) diluted to 10 ,ug/ml in 0.01 M phosphate-buffered saline (PBS), pH 7. The anti-C3 reagent was absorbed on insolubilized mouse immunoglobulins and affinity purified by chromatography on insolubilized human C3 (donated by Dr. J. Volanakis, University of Alabama at Birmingham). 100 !l aliquots of redissolved PEG precipitates were added to anti-C3-coated wells at a dilution equivalent to 1: 100 of the original serum volume. Plates were incubated at 37°C for 4 h, washed with PBS containing 0.05% Tween 20 (PBS-Tween), and subsequently exposed to biotinylated F(ab')2 fragments ofgoat antihuman IgA, IgM, or IgG (Tago, Inc., Burlingame, CA) appropriately diluted in PBS-0.05% Tween-5% FBS. The specificity of these reagents was established as previously described (44, 45) . After overnight incubation at 4°C, the plates were washed and subsequently incubated for 60 min with horseradish peroxidase-conjugated avidin (Sigma Chemical Co., St. Louis, MO) diluted to 0.5 ,g/ml in PBS-Tween-FBS. After washing, the plates were exposed to enzyme substrate consisting of2,2'-azinodi-(3-ethyl benzthiazoline sulfonic acid) (Sigma Chemical Co.) at a concentration of 0.25% (wt/vol) in 0. (50) antibodies as indicator reagents to detect bound RF. In addition, 25I-labeled mouse monoclonal anti-human IgAl or IgA2 antibodies were used to detect bound RF (49). Wells coated with bovine serum albumin (Sigma Chemical Co.) were used for control purposes. In some experiments, wells were coated with Fc and F(ab')2 fragments of human IgG to examine the specificity of the anti-IgG antibodies detected (50) .
Additionally, we used a modification ofa solid-phase enzyme-linked immunosorbent assay (ELISA) (42) for detection of RF. Affinity-purified F(ab')2 fragments of rabbit anti-human IgA or IgM (Pelfreeze, Rogers AZ) were used to capture immunoglobulins ofthe relevant isotype from serum samples. In order to detect RF activity in the bound immunoglobulins, soluble immune complexes consisting ofhorseradish peroxidase and rabbit IgG antiperoxidase antibodies (PAP) (Dakopats, Copenhagen, Denmark) were incubated on the plate. After washing and addition of enzyme substrate, the concentration of PAP bound to immobilized IgA or IgM RF was determined colorimetrically. IgG-RF levels were also examined by this procedure using a coating of affinity-purified F(ab')2 fragments of rabbit anti-human IgG (Jackson Laboratories, Inc., Avondale, PA). This technique will be referred to as ELISA-PAP. Results of the different RF assays are expressed in SDU as described above for the CIC assays.
Sedimentation properties ofCIC. Samples (0.3 ml) of freshly redissolved PEG precipitates were applied onto 4.7-ml linear gradients of 12-30% (wt/vol) sucrose preformed in 0.01 M PBS, pH 7.4. After ultracentrifugation at 37,500 rpm at 4°C for 16 h in a Beckman L2 ultracentrifuge using a SW 50.1 rotor, fractions (0.25 ml) were collected from the top. Prior to analysis for IgG-IgA1-or C3-IgAl-containing CIC, fractions were diluted (1:4 to 1:10) in CIC buffer. Standards consisted of purified IgG and IgM paraproteins.
Characterization ofIgA molecularforms in isolated CIC. Redissolved PEG precipitates equivalent to 2 ml of serum from three patients with high levels of IgA-CIC were incubated for 4 h at 370C with 1 ml of packed cyanogen bromide (CNBr)-activated Sepharose 4B beads (Pharmacia Fine Chemicals, Piscataway, NJ) to which F(ab')2 fragments of anti-human C3 or anti-human IgG Fc h4d been covalently coupled. With subclass-specific monoclonal anti-IgA reagents, 44% (11/25) of the patients had significantly higher levels of IgA 1-C3-containing CIC as compared with healthy volunteers (P < 0.001). In contrast, none of28 patients examined had evidence of IgA2-G3-containing CIC. Levels of IgA l-C3 CIC correlated with the magnitude of proteinuria (r = 0.44; P = 0.045) but not with serum creatinine concentrations (P > 0.5) or with the magnitude of hematuria (P > 0.5). IgG-C3-containing CIC were detected in 24% (5/21) of the patients studied and correlated with levels of CIC containing IgA l-C3 (r = 0.72, P = 0.0003).
IgM-G3-containing CIC were elevated in only 9% (2/21) of the patients tested.
CIC containing both IgG and IgA 1 were found significantly increased in 46% (12/30) of IgA NP patients as compared to a panel of sera from 14 healthy blood donors (P < 0.005) (Fig.  2) . IgG-IgA2-containing CIC were elevated in only 2 of 30 (7%) patients, both of whom also had IgG-IgA 1 CIC. There were no significant correlations between levels of IgG-IgA I CIC and either serum creatinine concentrations or magnitudes of protein- (Fig. 3) . CIC containing IgG and IgAl were predominantly of intermediate (13-19S) and occasionally of large (> 19S) size (Fig. 4) . Sucrose gradient analyses of affinity-isolated CIC containing C3 and IgA revealed the presence of a significant proportion of 7S IgA and of polymeric (or aggregated) IgA upon acid dissociation (Fig. 5) . The same type of analyses performed on isolated CIC containing both IgA and IgG indicated that the IgA component of these CIC was predominantly monomeric (Fig. 6) .
Serum levels ofRF. The presence of IgA l-IgG CIC in approximately one half of IgA NP patients raised the possibility that IgA anti-IgG antibodies might be a constituent of these complexes. In order to examine this possibility, RF levels were assayed in the serum of these patients. Serum levels of IgA RF were elevated in 28% (7/25) and 32% (8/25) of the patients as detected by RIA and ELISA PAP, respectively (Fig. 7) . IgM RF levels were within the normal range by both procedures with the exception of one patient who had increased serum levels of both IgA RF and IgA. Redissolved PEG precipitates from the sera from two patients with IgA NP were incubated with anti-C3-conjugated Sepharose 4B. Bound material was eluted with acid buffer. After ultracentrifugation on linear sucrose gradients in acid buffer, the collected fractions were neutralized, diluted 1:50, and subsequently assayed for IgA content by solid-phase RIA. Arrows indicate the position of the standards. These consisted of purified monomeric IgA (mIgA) and polymeric IgA (pIgA) paraproteins.
exhibited RF activity upon dissociation at acid pH. IgA RF was found predominantly in fractions corresponding to polymeric IgA (Fig. 9 ).
Discussion
Although IgA CIC levels have been correlated with episodes of nephritis and with recurrence of mesangial IgA nephropathy after renal transplantation (15) , others have shown that IgA CIC persist irrespective of clinical nephritis (20, 21, 25, 36 performed in our laboratory established that PEG precipitation was preferable to the use ofwhole sera because it provided more discriminative results in both CIC assays. Our experience is in agreement with Kauffman et al. (41), who have demonstrated the efficacy of PEG precipitation for the detection of IgA CIC. In this regard, pretreatment with PEG probably minimizes the competitive effects of free C3 and immunoglobulin present in whole serum.
In agreement with previous reports (14-26), we found that approximately half of the patients with IgA NP had increased levels of IgA-CIC detectable in the F(ab')2 anti-C3 assay. In addition, the IgA component of the anti-C3-reactive material was confined exclusively to the IgAl subclass. This finding is at vari- (58, 59) and humans (42 [7] and Lomax-Smith et al. [60] (34, 61) .
Levels of IgAl-C3 CIC correlated with the magnitude of proteinuria but not with the degree of renal insufficiency or the magnitude of hematuria. However, neither IgAl-IgG CIC nor IgA RF correlated with any of these indices of glomerular damage. This suggests that the different types of IgAl CIC may have Figure 9 . Sedimentation profile of IgA RF present in isolated CIC from two patients with IgA NP. CIC containing IgG and IgA were isolated by affinity chromatography on anti-IgG Sepharose 4B. After acid elution and sucrose gradient ultracentrifugation at acid pH, fractions containing polymeric (pIgA) or monomeric IgA (mIgA) were neutralized and assayed for IgA RF activity by 5 Ifrotcs solid-phase RIA as in Fig. 8 . different roles. Nevertheless, the clinical significance of our observations, their relationship to the development or progression ofrenal insufficiency in IgA NP, and their role in the pathogenesis of the disease must remain speculative at this time.
In conclusion, our immunochemical data taken together with previous immunohistochemical findings (18, (31) (32) (33) (34) suggest a dominant role of the IgA1 subclass in the pathogenesis of IgA NP. The lack of detectable alterations of the IgA compartment of mucosa-associated tissues (62) and the physical properties of the IgA1 associated with IgA CIC as well as IgA RF suggest a nonmucosal origin for a large proportion of these components.
